BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

745 related articles for article (PubMed ID: 24270265)

  • 1. Mammalian target of rapamycin complex 2 (mTORC2) coordinates pulmonary artery smooth muscle cell metabolism, proliferation, and survival in pulmonary arterial hypertension.
    Goncharov DA; Kudryashova TV; Ziai H; Ihida-Stansbury K; DeLisser H; Krymskaya VP; Tuder RM; Kawut SM; Goncharova EA
    Circulation; 2014 Feb; 129(8):864-74. PubMed ID: 24270265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Up-regulation of the mammalian target of rapamycin complex 1 subunit Raptor by aldosterone induces abnormal pulmonary artery smooth muscle cell survival patterns to promote pulmonary arterial hypertension.
    Aghamohammadzadeh R; Zhang YY; Stephens TE; Arons E; Zaman P; Polach KJ; Matar M; Yung LM; Yu PB; Bowman FP; Opotowsky AR; Waxman AB; Loscalzo J; Leopold JA; Maron BA
    FASEB J; 2016 Jul; 30(7):2511-27. PubMed ID: 27006450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological Inhibition of mTOR Kinase Reverses Right Ventricle Remodeling and Improves Right Ventricle Structure and Function in Rats.
    Pena A; Kobir A; Goncharov D; Goda A; Kudryashova TV; Ray A; Vanderpool R; Baust J; Chang B; Mora AL; Gorcsan J; Goncharova EA
    Am J Respir Cell Mol Biol; 2017 Nov; 57(5):615-625. PubMed ID: 28679058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. mTOR is required for pulmonary arterial vascular smooth muscle cell proliferation under chronic hypoxia.
    Krymskaya VP; Snow J; Cesarone G; Khavin I; Goncharov DA; Lim PN; Veasey SC; Ihida-Stansbury K; Jones PL; Goncharova EA
    FASEB J; 2011 Jun; 25(6):1922-33. PubMed ID: 21368105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIPPO-Integrin-linked Kinase Cross-Talk Controls Self-Sustaining Proliferation and Survival in Pulmonary Hypertension.
    Kudryashova TV; Goncharov DA; Pena A; Kelly N; Vanderpool R; Baust J; Kobir A; Shufesky W; Mora AL; Morelli AE; Zhao J; Ihida-Stansbury K; Chang B; DeLisser H; Tuder RM; Kawut SM; Silljé HH; Shapiro S; Zhao Y; Goncharova EA
    Am J Respir Crit Care Med; 2016 Oct; 194(7):866-877. PubMed ID: 27119551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of DP1 Aggravates Vascular Remodeling in Pulmonary Arterial Hypertension via mTORC1 Signaling.
    He Y; Zuo C; Jia D; Bai P; Kong D; Chen D; Liu G; Li J; Wang Y; Chen G; Yan S; Xiao B; Zhang J; Piao L; Li Y; Deng Y; Li B; Roux PP; Andreasson KI; Breyer RM; Su Y; Wang J; Lyu A; Shen Y; Yu Y
    Am J Respir Crit Care Med; 2020 May; 201(10):1263-1276. PubMed ID: 31917615
    [No Abstract]   [Full Text] [Related]  

  • 7. Calpain-2 activates Akt via TGF-β1-mTORC2 pathway in pulmonary artery smooth muscle cells.
    Abeyrathna P; Kovacs L; Han W; Su Y
    Am J Physiol Cell Physiol; 2016 Jul; 311(1):C24-34. PubMed ID: 27099352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective Tuberous Sclerosis Complex 1 Gene Deletion in Smooth Muscle Activates Mammalian Target of Rapamycin Signaling and Induces Pulmonary Hypertension.
    Houssaini A; Abid S; Derumeaux G; Wan F; Parpaleix A; Rideau D; Marcos E; Kebe K; Czibik G; Sawaki D; Treins C; Dubois-Randé JL; Li Z; Amsellem V; Lipskaia L; Pende M; Adnot S
    Am J Respir Cell Mol Biol; 2016 Sep; 55(3):352-67. PubMed ID: 26991739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. mTORC2 Signaling Regulates Nox4-Induced Podocyte Depletion in Diabetes.
    Eid S; Boutary S; Braych K; Sabra R; Massaad C; Hamdy A; Rashid A; Moodad S; Block K; Gorin Y; Abboud HE; Eid AA
    Antioxid Redox Signal; 2016 Nov; 25(13):703-719. PubMed ID: 27393154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. mTORC2 is required for proliferation and survival of TSC2-null cells.
    Goncharova EA; Goncharov DA; Li H; Pimtong W; Lu S; Khavin I; Krymskaya VP
    Mol Cell Biol; 2011 Jun; 31(12):2484-98. PubMed ID: 21482669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic Effects between mTOR Complex 1/2 and Glycolysis Inhibitors in Non-Small-Cell Lung Carcinoma Cells.
    Jiang S; Zou Z; Nie P; Wen R; Xiao Y; Tang J
    PLoS One; 2015; 10(7):e0132880. PubMed ID: 26176608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Critical Role of the mTOR/eIF2α Pathway in Hypoxia-Induced Pulmonary Hypertension.
    Wang AP; Li XH; Yang YM; Li WQ; Zhang W; Hu CP; Zhang Z; Li YJ
    PLoS One; 2015; 10(6):e0130806. PubMed ID: 26120832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profiling the role of mammalian target of rapamycin in the vascular smooth muscle metabolome in pulmonary arterial hypertension.
    Kudryashova TV; Goncharov DA; Pena A; Ihida-Stansbury K; DeLisser H; Kawut SM; Goncharova EA
    Pulm Circ; 2015 Dec; 5(4):667-80. PubMed ID: 26697174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia Increases IGFBP-1 Phosphorylation Mediated by mTOR Inhibition.
    Damerill I; Biggar KK; Abu Shehab M; Li SS; Jansson T; Gupta MB
    Mol Endocrinol; 2016 Feb; 30(2):201-16. PubMed ID: 26714229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noncanonical HIPPO/MST Signaling via BUB3 and FOXO Drives Pulmonary Vascular Cell Growth and Survival.
    Kudryashova TV; Dabral S; Nayakanti S; Ray A; Goncharov DA; Avolio T; Shen Y; Rode A; Pena A; Jiang L; Lin D; Baust J; Bachman TN; Graumann J; Ruppert C; Guenther A; Schmoranzer M; Grobs Y; Eve Lemay S; Tremblay E; Breuils-Bonnet S; Boucherat O; Mora AL; DeLisser H; Zhao J; Zhao Y; Bonnet S; Seeger W; Pullamsetti SS; Goncharova EA
    Circ Res; 2022 Mar; 130(5):760-778. PubMed ID: 35124974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting of mTORC2 may have advantages over selective targeting of mTORC1 in the treatment of malignant pheochromocytoma.
    Zhang X; Wang X; Xu T; Zhong S; Shen Z
    Tumour Biol; 2015 Jul; 36(7):5273-81. PubMed ID: 25666752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapamycin reverses pulmonary artery smooth muscle cell proliferation in pulmonary hypertension.
    Houssaini A; Abid S; Mouraret N; Wan F; Rideau D; Saker M; Marcos E; Tissot CM; Dubois-Randé JL; Amsellem V; Adnot S
    Am J Respir Cell Mol Biol; 2013 May; 48(5):568-77. PubMed ID: 23470622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanistic target of rapamycin complex 2 protects the heart from ischemic damage.
    Völkers M; Konstandin MH; Doroudgar S; Toko H; Quijada P; Din S; Joyo A; Ornelas L; Samse K; Thuerauf DJ; Gude N; Glembotski CC; Sussman MA
    Circulation; 2013 Nov; 128(19):2132-44. PubMed ID: 24008870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. mTOR has a developmental stage-specific role in mitochondrial fitness independent of conventional mTORC1 and mTORC2 and the kinase activity.
    Kalim KW; Zhang S; Chen X; Li Y; Yang JQ; Zheng Y; Guo F
    PLoS One; 2017; 12(8):e0183266. PubMed ID: 28813526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CPT1 regulates the proliferation of pulmonary artery smooth muscle cells through the AMPK-p53-p21 pathway in pulmonary arterial hypertension.
    Zhuang W; Lian G; Huang B; Du A; Gong J; Xiao G; Xu C; Wang H; Xie L
    Mol Cell Biochem; 2019 May; 455(1-2):169-183. PubMed ID: 30511343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.